Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced the publication in Science Immunology of preclinical data demonstrating the potential of IPH6501, ...
Results from a new animal study found that maternal exposure to e-cigarette residues, with or without nicotine, affected ...
LIfT BioSciences, a rapidly emerging biotech company preparing to start clinical trials for its first-in-class allogeneic innate cell therapy ... to give a durable response and long-lasting ...
Vir Biotechnology, Inc. today announced positive results from the SOLSTICE Phase 2 clinical trial evaluating tobevibart alone, or in combination with elebsiran, in people with chronic hepatitis delta ...
It appears that the fungus allows the Ork’s body to negate the use of complex internal organs, the immune system, and the ...
A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...
Global transcriptional changes in MANC immune cells reveal expanded expression of neutrophil markers across multiple cell lineages In addition to the abovementioned phenotypes, many other interesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback